Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
These effects can be quite profound and unpleasant, especially when lifestyle isnt properly modified, leading to over 50% of patients prescribed GLP-1s for obesity discontinuing the drug within 12 months
Higher doses cost more
/assets/images/provider/photos/2775905.jpeg)
Most weight loss programs focus on short-term results
We will not share your information for any other purposes
They are not indicated for type 1 diabetes or diabetic ketoacidosis
Eli Lillys investigational triple-agonist remains in Phase 3 clinical trials (the TRIUMPH program), with the earliest plausible New Drug Application filing in Q4 2026 and a potential FDA decision in 2027 or 2028
US$ 22.86
US$ 27.71
:max_bytes(150000):strip_icc()/GettyImages-1470213196-a19fb8f0142542be837a35951bbc80cd.jpg)
US$ 22.35
